*
China pledges equal treatment for foreign firms
*
German VDMA: announcement part of 'friendly signs'
offensive
*
Move aimed at keeping foreign firms engaged in China
By Christoph Steitz and Rene Wagner
FRANKFURT/BERLIN, March 25 (Reuters) - A fresh pledge by
Beijing to treat foreign companies like domestic rivals drew a
cool response from one of its biggest trading partners, Germany,
where industries called for concrete actions rather than words
to create a true level-playing field.
Germany's engagement in the world's No.2 economy has been in
focus, partly because China remains its biggest trading partner
but also because Berlin has asked companies to diversify away
from what it calls "partner, competitor and systemic rival".
Beijing's efforts to make sure international companies stay
engaged come as inbound foreign direct investment shrank by 8%
in 2023, partly a result of broader anti-espionage laws, exit
bans and raids on consultancies and due diligence firms.
German direct investment in China, however, rose to a record
high of 11.9 billion euros ($12.9 billion) last year,
underscoring how relevant the market remains despite efforts to
reduce exposure.
In a bid to attract more foreign money, Chinese Vice
Commerce Minister Guo Tingting told the China Development Forum
in Beijing that the country would "fully guarantee national
treatment for foreign companies", without elaborating further.
"We are seeing more and more of what I'll call it friendly
signals," said Oliver Wack, Asia expert at German engineering
association VDMA, which represents heavyweights including
Siemens and Thyssenkrupp.
"But in terms of content, this is not exactly
earth-shattering."
MORE THAN WORDS?
Wack said efforts by Beijing included a Dec. 12 meeting with
the head of economics at China's consulate general in Frankfurt
who asked what had to be done to encourage more of the VDMA's
members to invest in China.
As part of a series of events this week in the Chinese
capital with foreign companies, the Ministry of Commerce will
hold the Invest in China Summit 2024 on Tuesday, where Pfizer ( PFE )
CEO Albert Bourla and AstraZeneca ( AZN ) CEO Pascal
Soriot are due to speak, according to a schedule.
AstraZeneca ( AZN ) declined to comment and Pfizer ( PFE ) confirmed Bourla
attending China Development Forum and speaking on a panel at the
Invest in China Summit, but declined to comment further.
The Wall Street Journal separately reported that Chinese
leader Xi Jinping plans to meet a group of U.S. business leaders
this week after the forum as Beijing steps up efforts to woo
American firms amid an exodus of foreign capital.
VDMA's Wack said in order to make effective changes China
should join the World Trade Organisation's Government
Procurement Agreement and the OECD. Both would be tangible steps
to create equality among companies.
Dirk Jandura, president of the Federation of German
Wholesale, Foreign Trade and Services, also poured cold water on
hopes that the latest Chinese push would really change things.
"We are familiar with these kind of promises. Unfortunately,
in the past, it has often remained just words, or changes have
been made in small steps ... The extent to which foreign
entrepreneurs can make a contribution here remains unclear."
($1 = 0.9236 euros)
(Reporting by Christoph Steitz and Rene Wagner; Additional
reporting by Maggie Fick in London; Editing by Ros Russell)